CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia-Reference-Cited by-同舟云学术

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Published:2006-04-06 Issue:5 Volume:129 Page:1177-1187
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Bibl Mirko,Mollenhauer Brit,Esselmann Hermann,Lewczuk Piotr,Klafki Hans-Wolfgang,Sparbier Katrin,Smirnov Alexandr,Cepek Lukas,Trenkwalder Claudia,Rüther Eckart,Kornhuber Johannes,Otto Markus,Wiltfang Jens

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/129/5/1177/13733923/awl063.pdf

Reference51 articles.

1. Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, et al. Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol2001; 58: 373–9.

2. Andreasen N, Sjogren M, Blennow K. CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42. World J Biol Psychiatry2003; 4: 147–55.

3. Atwood CS, Martins RN, Smith MA, Perry G. Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins. Peptides2002; 23: 1343–50

4. Barnham KJ, Ciccotosto GD, Tickler AK, Ali FE, Smith DG, Williamson MA, et al. Neurotoxic, redox-competent Alzheimer's β-Amyloid is released from lipid membrane by methionine oxidation. J Biol Chem2003; 278: 42959–65.

5. Bibl M, Esselmann H, Otto M, Lewczuk P, Cepek L, Rüther E, et al. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pre-treatment: Indication of carrier-mediated epitope masking of amyloid beta peptides. Electrophoresis2004; 25: 2912–8.

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cell therapy for Alzheimer’s disease: A novel therapeutic approach for neurodegenerative diseases;Neuroscience;2024-09

2. Bifurcations in coupled amyloid-β aggregation-inflammation systems;npj Systems Biology and Applications;2024-07-30

3. Heparan sulfate proteoglycans: Mediators of cellular and molecular Alzheimer's disease pathogenic factors via tunnelling nanotubes?;Molecular and Cellular Neuroscience;2024-06

4. Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy;Protein & Cell;2024-05-11

5. Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform;The Journal of Applied Laboratory Medicine;2024-05-07